arGEN-X advances a third therapeutic antibody program into preclinical development: http://t.co/hBB8aUOQ
posted 1 day ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
J&J snoeit opnieuw in verwachtingen (het volledige artikel is enkel beschikbaar voor abonnees van De Tijd)
Source: De Tijd
Tags: financing